{
    "clinical_study": {
        "@rank": "105879", 
        "acronym": "COMPASS", 
        "arm_group": [
            {
                "arm_group_label": "Intervention", 
                "arm_group_type": "Experimental", 
                "description": "Incident peritoneal dialysis (PD) patients who are randomly allocated to BCM-guided fluid management will receive BCM measurement every two months over 1-year period. The BCM results will be notified to the physicians and the participating subjects. Based on the BCM results along with the clinical information such as blood pressure, edema and weight, the physicians will prescribe PD fluid and diuretics, targeting within 1L of overhydration status. They will prescribe dietary education to the patient, if necessary."
            }, 
            {
                "arm_group_label": "Control", 
                "arm_group_type": "Active Comparator", 
                "description": "BCM will be measured at the beginning and end of the study, respectively. However, the BCM results will be blinded to the physicians and the control group. The physician will prescribe drugs, PD fluids, and dietary education to the patients based on the clinical information alone - such as blood pressure, edema and body weight."
            }
        ], 
        "brief_summary": {
            "textblock": "Bioimpedance-guided fluid management in peritoneal dialysis patients may provide better\n      protection of residual renal function over 1 year period, compared with management guided by\n      clinical information alone - such as blood pressure, body weight, and physician's physical\n      examination."
        }, 
        "brief_title": "Control Of Fluid Balance Guided by Body Composition Monitoring in Patients on PeritoneAl dialySiS", 
        "completion_date": {
            "#text": "July 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Peritoneal Dialysis, Continuous Ambulatory", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  age bwten 20 and 75\n\n          -  peritoneal dialysis > 4 weeks duration\n\n          -  written consent\n\n          -  daily urine output > 500 ml\n\n        Exclusion Criteria:\n\n          -  subjects who are contraindicated to the bioimpedance measurement (pacemaker insertion\n             state, defibrillator state, amputee, prosthesis, metal implants)\n\n          -  pregnant women\n\n          -  subjects who are expected to discontinue peritoneal dialysis with one year\n\n          -  mixed dialysis modality (peritoneal + hemodialysis)\n\n          -  hypoalbuminemic subjects (serum albumin < 3.3 g/dL)\n\n          -  high blood pressure (> 160/100 mmHg despite antihypertensive medications)\n\n          -  severe heart failure (NYHA FC III, or IV)"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "75 Years", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "138", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "June 24, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01887262", 
            "org_study_id": "COMPASS"
        }, 
        "intervention": [
            {
                "arm_group_label": "Intervention", 
                "intervention_name": "BCM-guided fluid management", 
                "intervention_type": "Device"
            }, 
            {
                "arm_group_label": "Control", 
                "intervention_name": "Fluid management based on the clinical information alone", 
                "intervention_type": "Procedure"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "fluid", 
            "edema"
        ], 
        "lastchanged_date": "June 25, 2013", 
        "location": {
            "contact": {
                "email": "snuhirb@gmail.com", 
                "last_name": "SuJin Cho", 
                "phone": "82 2 2072 0694"
            }, 
            "facility": {
                "address": {
                    "city": "Seoul", 
                    "country": "Korea, Republic of", 
                    "zip": "110-744"
                }, 
                "name": "Seoul National University Hospital Clinical Trial Center"
            }, 
            "investigator": {
                "last_name": "Kook-Hwan Oh, MD PhD", 
                "role": "Principal Investigator"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_arms": "2", 
        "official_title": "Control Of Fluid Balance Guided by Body Composition Monitoring in Patients on PeritoneAl dialySiS (COMPASS) Trial", 
        "overall_contact": {
            "last_name": "Kook-Hwan Oh, M.D, Ph.D", 
            "phone": "82 2 2072 0776"
        }, 
        "overall_contact_backup": {
            "last_name": "Ki-Young Na, M.D, Ph.D", 
            "phone": "82 10 9267 4315"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "Korea: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "May 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "change of glomerular filtration rate from baseline to the 12th month", 
            "measure": "delta GFR", 
            "safety_issue": "No", 
            "time_frame": "baseline and 12th  month"
        }, 
        "reference": {
            "PMID": "21390320", 
            "citation": "Van Biesen W, Williams JD, Covic AC, Fan S, Claes K, Lichodziejewska-Niemierko M, Verger C, Steiger J, Schoder V, Wabel P, Gauly A, Himmele R; EuroBCM Study Group. Fluid status in peritoneal dialysis patients: the European Body Composition Monitoring (EuroBCM) study cohort. PLoS One. 2011 Feb 24;6(2):e17148. doi: 10.1371/journal.pone.0017148."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01887262"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Seoul National University Hospital", 
            "investigator_full_name": "Kook-Hwan Oh", 
            "investigator_title": "Associate Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "glomerular filtration rate measured by urine collection, calculated by the mean of creatinine and urea clearance", 
                "measure": "GFR", 
                "safety_issue": "No", 
                "time_frame": "at 12th month"
            }, 
            {
                "description": "time to the anuric state (urine volume < 100cc/d)", 
                "measure": "time to anuria", 
                "safety_issue": "No", 
                "time_frame": "over 12 months"
            }, 
            {
                "description": "parameters obtained by echocardiographic measurements such as left ventracular mass index (LVMi), E/e' ratio, left vetricular end-diastolic volume (LVEDP), left ventracular ejection fraction (LVEF), left atrial volume indx (LAVI)", 
                "measure": "echocardiographic parameters", 
                "safety_issue": "No", 
                "time_frame": "12 months period"
            }, 
            {
                "description": "systolic, diastolic blood pressure, pulse pressure", 
                "measure": "BP", 
                "safety_issue": "No", 
                "time_frame": "12th month"
            }, 
            {
                "description": "fatal and nonfatal cardiovascular events - acute myocardial infarction (AMI), stroke, unstable angina, amputation, cardiovascular revascularization", 
                "measure": "cardiovascular event", 
                "safety_issue": "No", 
                "time_frame": "over 12 months"
            }, 
            {
                "description": "parameters measured by body composition monitoring (BCM), such as overhydration(OH), extracellular water (ECW), extracellular-to-intracellular water ratio (ECW/ICW)", 
                "measure": "BCM parameters", 
                "safety_issue": "No", 
                "time_frame": "baseline and 12th month"
            }
        ], 
        "source": "Seoul National University Hospital", 
        "sponsors": {
            "collaborator": {
                "agency": "Fresenius Medical Care Korea", 
                "agency_class": "Industry"
            }, 
            "lead_sponsor": {
                "agency": "Seoul National University Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "July 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Diagnostic", 
        "study_type": "Interventional", 
        "verification_date": "June 2013"
    }
}